Treatment of chronic akinetic mutism with atomoxetine: subtraction analysis of brain f-18 fluorodeoxyglucose positron emission tomographic images before and after medication: a case report

Akinetic mutism is a rare, complex neuropathologic disorder. The pharmaceutical treatment of akinetic mutism typically includes dopaminergic agents, but the resulting therapeutic effects are often unsatisfactory, and it remains unclear whether late treatment using these medications is effective. We...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical neuropharmacology Vol. 33; no. 4; p. 209
Main Authors:	Kim, Yong Wook, Shin, Ji-Cheol, An, Young-Sil
Format:	Journal Article
Language:	English
Published:	United States 01.07.2010
Subjects:	Akinetic Mutism - diagnostic imaging Akinetic Mutism - drug therapy Akinetic Mutism - metabolism Aneurysm, Ruptured - complications Atomoxetine Hydrochloride Cognition - drug effects Fluorodeoxyglucose F18 - metabolism Frontal Lobe - diagnostic imaging Frontal Lobe - drug effects Frontal Lobe - metabolism Glucose - metabolism Humans Male Middle Aged Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors Occipital Lobe - diagnostic imaging Occipital Lobe - drug effects Occipital Lobe - metabolism Positron-Emission Tomography Propylamines - therapeutic use Subarachnoid Hemorrhage - etiology Subtraction Technique Time Factors
ISSN:	1537-162X, 1537-162X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!